Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Multiple Myeloma"
topic_facet:"Neoplasms, Plasma Cell"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=topic_facet%3A%22Neoplasms%2C+Plasma+Cell%22&lookfor=%22Myeloma%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=topic_facet%3A%22Neoplasms%2C+Plasma+Cell%22&lookfor=%22Myeloma%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=topic_facet%3A%22Neoplasms%2C+Plasma+Cell%22&lookfor=%22Myeloma%22&type=Subject
PubPharm (2.644)
1
Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation : Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule(s) and Dose(s) of Melphalan for Injection (Evomela) as a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma : Phase I Study of Autologous CAR T-Cells Targeting the CD138 Antigen for Relapsed or Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients : A Single Arm, Response-adapted, Open Label Study of Iberdomide, Weekly Bortezomib and Dexamethasone (IberBd) With Isatuximab Added on Demand for Transplant-ineligible, Newly Diagnosed Multiple Myeloma Patients: the BOREALIS Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS : Phase 2 Study Applying Innovative Minimal Residual Disease (MRD) Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by Autologous Stem Cell Transplantation (ASCT) - TAURUS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma : An Exploratory Clinical Study of the Safety and Efficacy of NKG2D Chimeric Antigen Receptor NK Cell Injections for the Treatment of Efractory Recurrent Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) : Molecular Analysis for Therapy Choice (MATCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Study to Determine Dose, Safety, Tolerability, Drug Levels, and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Participants With Multiple Myeloma : A Phase 1b/2a Multicenter, Open-label, Dose-escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination With Other Treatments in Subjects With Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients : Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients (SABLe): An Investigator Sponsored Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) : A Phase III Randomized, Controlled, Multicenter, Open-label Study of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma : Comparative Effectiveness of Elranatamab (PF 06863135) in Clinical Study C1071003 Versus Standard of Care (SOC) in Real-World (RW) External Control Arms in Patients With Triple-Class Refractory (TCR) Multiple Myeloma (MM)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[265]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Multiple Myeloma
Filter aufheben
Thema: Neoplasms, Plasma Cell
Medienart
2.644
E-Ressourcen
2.643
Aufsätze
2.643
E-Artikel
1
Bücher
1
E-Books
Alle anzeigen ...
weniger ...
Zeitschriftentitel
2.642
ClinicalTrials.gov
1
Journal of chiropractic medicine
Thema
Multiple Myeloma
Neoplasms, Plasma Cell
2.642
610
2.301
Study Type: Interventional
992
Recruitment Status: Completed
814
Phase: Phase 2
751
Medical Condition: Multiple Myeloma
601
Recruitment Status: Recruiting
555
Phase: Phase 1
364
Recruitment Status: Active, not recruiting
312
Study Type: Observational
311
Recruitment Status: Terminated
272
Phase: Phase 3
229
Lymphoma
212
Phase: Phase 1, Phase 2
175
Leukemia
159
Phase: Phase 1/Phase 2
120
Myelodysplastic Syndromes
117
Recruitment Status: Not yet recruiting
113
Plasmacytoma
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.689
2020-
912
2010-2019
43
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.644
Englisch
Haven't found what you're looking for?
Wird geladen...